An unprecedented suppression of malignancy by hetero- or homologous loss of Rlip in p53-null mice, along with p53 abnormality in the majority of breast cancers, suggests an existential importance of Rlip in breast cancer. This evidence concerns the gene TP53 and breast cancer.